PROCEPT BioRobotics (PRCT) Income towards Parent Company (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Income towards Parent Company for 7 consecutive years, with -$31.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Income towards Parent Company fell 27.9% year-over-year to -$31.6 million; the TTM figure through Mar 2026 stood at -$185.1 million (down 64.85% YoY), while the FY2025 annual figure was -$95.6 million, down 4.55% from the prior year.
• Income towards Parent Company climbed to -$31.6 million in Q1 2026 per PRCT's latest filing, from -$31.9 million in the prior quarter.
• Across five years, Income towards Parent Company topped out at -$19.3 million in Q2 2022 and bottomed at -$78.0 million in Q1 2023.
• Historically, Income towards Parent Company has averaged -$36.8 million across 5 years, with a median of -$31.9 million in 2025.
• Annual changes were most pronounced in 2023 — Income towards Parent Company plunged 296.97% — and 2024, when it soared 46.71%.
• PROCEPT BioRobotics' Income towards Parent Company stood at -$24.0 million in 2022, then tumbled by 33.97% to -$32.1 million in 2023, then surged by 35.08% to -$20.8 million in 2024, then plunged by 52.88% to -$31.9 million in 2025, then gained by 0.73% to -$31.6 million in 2026.
• Business Quant data shows PRCT's Income towards Parent Company at -$31.6 million in Q1 2026, -$31.9 million in Q4 2025, and -$60.7 million in Q3 2025.